Current World Literature

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Current Opinion in HIV and AIDS

• Publication date

  2003-08-01

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1097/COH.0b013e32835c107dPMID 23211780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug induced hypertension--An unappreciated cause of secondary hypertension.

  2015cited by this paper
• HIV and noncommunicable diseases: a case for health system building

  2013cited by this paper
• Provider-Initiated HIV Testing and Counseling in Low- and Middle-Income Countries: A Systematic Review

  2013cited by this paper
• Drug-resistant HIV-1 in sub-Saharan Africa: clinical and public health studies

  2013cited by this paper
• HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea.

  2012cited by this paper
• Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam.

  2012cited by this paper
• Treatment Outcomes From the Largest Antiretroviral Treatment Program in Myanmar (Burma): A Cohort Analysis of Retention After Scale-Up

  2012cited by this paper
• A Randomized Comparison of Second-Line Lopinavir/ Ritonavir Monotherapy versus Tenofovir/Lamivudine/ Lopinavir/Ritonavir in Patients Failing Nnrti Regimens: The HIV Star Study

  2012cited by this paper
• Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial.

  2012cited by this paper
• Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough?

  2012cited by this paper
• Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050

  2012cited by this paper
• Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, India.

  2012cited by this paper
• High prevalence of cervical squamous intraepithelial lesions in women on antiretroviral therapy in Cameroon: Is targeted screening feasible?

  2012cited by this paper
• Short-course raltegravir intensification does not increase 2 long terminal repeat episomal HIV-1 DNA in patients on effective antiretroviral therapy.

  2012cited by this paper
• Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

  2012cited by this paper
• Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents

  2012cited by this paper
• HIV Type 1 Gag as a Target for Antiviral Therapy

  2012cited by this paper
• Pregnancy and Infant Outcomes among HIV-Infected Women Taking Long-Term ART with and without Tenofovir in the DART Trial

  2012cited by this paper
• Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa.

  2012cited by this paper
• Overview of microbicides for the prevention of human immunodeficiency virus.

  2012cited by this paper
• Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.

  2012cited by this paper
• Prediction of treatment failure using 2010 World Health Organization Guidelines is associated with high misclassification rates and drug resistance among HIV-infected Cambodian children.

  2012cited by this paper
• Building capacity for the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to Evaluate Resistance network.

  2012cited by this paper
• Chronic care of HIV and noncommunicable diseases How to leverage tHe HIv experIence

  2012cited by this paper
• Less decrease in risk behaviour from pre-HIV to post-HIV seroconversion among MSM in the combination antiretroviral therapy era compared with the pre-combination antiretroviral therapy era

  2012cited by this paper
• Drug Resistance Pattern of HIV Type 1 Isolates Sampled in 2007 from Therapy-Naive Pregnant Women in North-Central Nigeria

  2012cited by this paper
• A Randomized Trial of Noninvasive Positive End Expiratory Pressure in Patients With Acquired Immune Deficiency Syndrome and Hypoxemic Respiratory Failure

  2012cited by this paper
• The impact of first year adherence to antiretroviral therapy on long‐term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe

  2012cited by this paper
• Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens

  2012cited by this paper
• Pre-ART HIV resistance testing in Africa: are we there yet?

  2012cited by this paper
• Virologic suppression in nevirapine-exposed HIV-infected infants initiating antiretroviral therapy in rural Uganda.

  2012cited by this paper
• Unresolved Antiretroviral Treatment Management Issues in HIV-Infected Children

  2012cited by this paper
• Elvitegravir: a once-daily inhibitor of HIV-1 integrase

  2012cited by this paper
• Prevalence of Congenital Anomalies in Infants With In Utero Exposure to Antiretrovirals

  2012cited by this paper
• No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial

  2012cited by this paper
• Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan.

  2012cited by this paper
• Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.

  2012cited by this paper
• Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers

  2012cited by this paper
• Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.

  2012cited by this paper
• Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation.

  2012cited by this paper
• Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.

  2012cited by this paper
• Human Cytomegalovirus Infant Infection Adversely Affects Growth and Development in Maternally HIV-Exposed and Unexposed Infants in Zambia

  2012cited by this paper
• Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis

  2012cited by this paper
• Surveillance of transmitted HIV drug resistance using matched plasma and dried blood spot specimens from voluntary counseling and testing sites in Ho Chi Minh City, Vietnam, 2007-2008.

  2012cited by this paper
• Effect of cotrimoxazole on mortality in HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis.

  2012cited by this paper
• Supporting the massive scale-up of antiretroviral therapy: the evolution of PEPFAR-supported treatment facilities in South Africa, 2005-2009

  2012cited by this paper
• Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia.

  2012cited by this paper
• Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database Analysis

  2012cited by this paper
• Antiretroviral drug treatment of CNS HIV-1 infection.

  2012cited by this paper
• Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

  2012cited by this paper
• Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy

  2012cited by this paper
• Efficacy of Antiretroviral Therapy Switch in HIV-Infected Patients: A 10-Year Analysis of the EuResist Cohort

  2012cited by this paper
• Evaluation of Viral Load Thresholds for Predicting New World Health Organization Stage 3 and 4 Events in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy

  2012cited by this paper
• Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study.

  2012cited by this paper
• Treatment outcomes of patients on second-line antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis

  2012cited by this paper
• Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis

  2012cited by this paper
• Epidemiology of Transmitted Drug Resistance in Chronically HIV-Infected Patients in Germany: The RESINA Study 2001–2009

  2012cited by this paper
• A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection

  2012cited by this paper
• Political lessons from the global HIV/AIDS response to inform a rapid noncommunicable disease response.

  2012cited by this paper
• Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysis.

  2012cited by this paper
• HIV/AIDS profile and realities at a regional antiretroviral therapy clinic in Jerusalem: 12 years analysis

  2012cited by this paper
• Food insecurity is associated with morbidity and patterns of healthcare utilization among HIV-infected individuals in a resource-poor setting

  2012cited by this paper
• HIV infection and risk of overdose: a systematic review and meta-analysis

  2012cited by this paper
• Reduced Antituberculosis Drug Concentrations in HIV-Infected Patients Who Are Men or Have Low Weight: Implications for International Dosing Guidelines

  2012cited by this paper
• Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy.

  2012cited by this paper
• Hormonal contraception and the risk of HIV acquisition among women in South Africa

  2012cited by this paper
• Management of the metabolic effects of HIV and HIV drugs

  2012cited by this paper
• Accumulation of HIV Drug Resistance Mutations in Patients Failing First-Line Antiretroviral Treatment in South Africa

  2012cited by this paper
• Human immunodeficiency virus‐associated lung cancer in the era of highly active antiretroviral therapy

  2012cited by this paper
• Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

  2012cited by this paper
• Experience in piloting HIV drug resistance early warning indicators to improve the antiretroviral program in Papua New Guinea.

  2012cited by this paper
• Very late initiation of HAART impairs treatment response at 48 and 96 weeks: results from a meta-analysis of randomized clinical trials.

  2012cited by this paper
• HIV, aging and continuity care: strengthening health systems to support services for noncommunicable diseases in low-income countries

  2012cited by this paper
• Paradoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection.

  2012cited by this paper
• A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa

  2012cited by this paper
• Psychopharmacological treatments in HIV patients under antiretroviral therapy.

  2012cited by this paper
• Positioning of HIV-protease inhibitors in clinical practice.

  2012cited by this paper
• Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda.

  2012cited by this paper
• The Prevalence of Drug Resistance Mutations Among Treatment-Naive HIV-Infected Individuals in Beijing, China

  2012cited by this paper
• Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009.

  2012cited by this paper
• Different Baseline Characteristics and Different Outcomes of HIV-Infected Patients Receiving HAART Through Clinical Trials Compared With Routine Care in Mexico

  2012cited by this paper
• The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.

  2012cited by this paper
• The effect of injecting drug use history on disease progression and death among HIV‐positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis

  2012cited by this paper
• Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial

  2012cited by this paper
• Influence of Antituberculosis Drug Resistance and Mycobacterium tuberculosis Lineage on Outcome in HIV-Associated Tuberculous Meningitis

  2012cited by this paper
• Accelerated aging and human immunodeficiency virus infection: Emerging challenges of growing older in the era of successful antiretroviral therapy

  2012cited by this paper
• Surveys of transmitted HIV drug resistance in 7 geographic Regions in China, 2008-2009.

  2012cited by this paper
• Primary Drug Resistance in South Africa: Data from 10 Years of Surveys

  2012cited by this paper
• Preexposure prophylaxis for HIV infection among African women.

  2012cited by this paper
• Views of policymakers, healthcare workers and NGOs on HIV pre-exposure prophylaxis (PrEP): a multinational qualitative study

  2012cited by this paper
• Transmitted Drug-Resistant HIV Type 1 Remains Prevalent and Impacts Virologic Outcomes Despite Genotype-Guided Antiretroviral Therapy

  2012cited by this paper
• Unpacking the recommended indicator for concurrent sexual partnerships

  2012cited by this paper
• Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factors.

  2012cited by this paper
• Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection.

  2012cited by this paper
• New DHHS guidelines recommend antiretroviral therapy to all HIV-infected persons.

  2012cited by this paper
• Stable bone mineral density over 6 years in HIV‐infected men treated with highly active antiretroviral therapy (HAART)

  2012cited by this paper
• HIV medications: an update and review of metabolic complications.

  2012cited by this paper
• Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn

  2012cited by this paper
• HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy

  2012cited by this paper
• Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents

  2012cited by this paper

• No citing papers are available for this paper.